Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Testing control settings of a wearable leg robot to help walking after stroke

Tests how a wearable leg robot is controlled in adults recovering from stroke.

Plain-language title generated from the registry record
Registry title: The Effects of the Control Strategies of Wearable Lower Limb Rehabilitation Robots

Key facts

Where
Shenzhen, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT07037849, who can take part

Where in China

  • Eight affiliated hospital, Sun Yat-Sen UniversityShenzhen, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Eighth Affiliated Hospital, Sun Yat-sen University
Trial code
NCT07037849
Record updated
26 June 2025
Original description
Post-stroke patients were required to complete a session of robot-assisted training, which involved nine repetitions of 5-meter overground walking (three trials for each of the three controllers) in a rectangular hospital corridor.Read full original descriptionShow less

Effects of Control Strategies in Wearable Lower Limb Rehabilitation Robots

Post-stroke patients were required to complete a session of robot-assisted training, which involved nine repetitions of 5-meter overground walking (three trials for each of the three controllers) in a rectangular hospital corridor.

Inclusion: Stroke patients aged between 18 and 75 years. Patients who are medically stable and able to stand and walk independently for at least 10 meters during rehabilitation; Stroke event occurred at least 3 months ago Patients with impaired lower limb motor function but with some degree of muscle activity in the lower extremities; Patients without severe cognitive impairment and capable of understanding and following the treatment protocol; Patients without severe balance or coordination disorders, able to maintain balance and perform gait training with assistive devices; Patients without lower limb fractures or other serious skeletal issues affecting the lower limbs; Patients without severe cardiovascular or other serious illnesses and able to tolerate the intensity and duration of rehabilitation therapy; Patients willing to participate in the study and able to provide written informed consent.

Exclusion: Lower limb fractures or other serious skeletal issues that may impact the suitability and safety of robot-assisted rehabilitation therapy; Patients currently receiving other rehabilitation or experimental treatments. Patients with skin ulcers, infections, or other severe skin conditions that may interfere with the use and application of robotic devices; Unexplained discomfort or pain symptoms that may limit the patient's ability to participate in rehabilitation therapy; Severe cognitive impairment that prevents the patient from understanding or complying with the treatment protocol; Severe balance or coordination disorders that prevent the patient from maintaining balance and participating in gait training, even with assistive devices; Other serious motor disorders, such as abnormal muscle tone or ataxia, which may interfere with the effectiveness of rehabilitation therapy; Active cardiovascular disease or other serious systemic illnesses that may affect the patient's safety or treatment outcomes; Failure to meet other specific inclusion criteria outlined in the study protocol.

ClinicalTrials.gov NCT07037849